U.S. Top Stock Picks from Analysts

Strategy

Market Cap: US$95.7b

Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.

Atlassian

Market Cap: US$44.8b

Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

QXO

Market Cap: US$12.7b

Distributes roofing, waterproofing, and other building products in the United States.

BioMarin Pharmaceutical

Market Cap: US$11.2b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Aurora Innovation

Market Cap: US$10.8b

Operates as a self-driving technology company in the United States.

U-Haul Holding

Market Cap: US$10.3b

Operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada.

Moderna

Market Cap: US$10.2b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

monday.com

Market Cap: US$8.8b

Develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally.

Liberty Broadband

Market Cap: US$8.8b

Engages in a range of communications businesses in the United States.

VinFast Auto

Market Cap: US$8.0b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

Corcept Therapeutics

Market Cap: US$7.5b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Wix.com

Market Cap: US$7.4b

Operates a cloud-based web development platform for registered users and creators worldwide.

Revolution Medicines

Market Cap: US$6.8b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Legend Biotech

Market Cap: US$6.6b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Nuvalent

Market Cap: US$5.3b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Caesars Entertainment

Market Cap: US$5.2b

Operates as a gaming and hospitality company.

CRISPR Therapeutics

Market Cap: US$4.8b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Cytokinetics

Market Cap: US$4.6b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Chagee Holdings

Market Cap: US$4.2b

Through its subsidiaries, owns, operates, and franchises teahouses under the CHAGEE brand name in the People’s Republic of China and internationally.

Vaxcyte

Market Cap: US$4.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

ADMA Biologics

Market Cap: US$4.1b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Qfin Holdings

Market Cap: US$4.1b

Qfin Holdings, Inc., together with its subsidiaries, operate AI- driven credit-tech platform under the Qifu Jietiao brand in the People’s Republic of China.

Lantheus Holdings

Market Cap: US$4.0b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Arcellx

Market Cap: US$4.0b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Akero Therapeutics

Market Cap: US$3.9b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Remitly Global

Market Cap: US$3.8b

Engages in the provision of digital financial services in the United States, Canada, and internationally.

Zai Lab

Market Cap: US$3.8b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Soleno Therapeutics

Market Cap: US$3.7b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Metsera

Market Cap: US$3.4b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

Globalstar

Market Cap: US$3.3b

Provides mobile satellite services in the United States, Canada, Europe, Central and South America, and internationally.

Globant

Market Cap: US$3.0b

Provides technology services worldwide.

GEO Group

Market Cap: US$2.9b

Owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.

Viking Therapeutics

Market Cap: US$2.9b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Arrowhead Pharmaceuticals

Market Cap: US$2.9b

Develops medicines for the treatment of intractable diseases in the United States.

Ultragenyx Pharmaceutical

Market Cap: US$2.8b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Braze

Market Cap: US$2.8b

Operates a customer engagement platform that provides interactions between consumers and brands worldwide.